A real-world study of grass-pollen SLIT tablets in controlling allergic rhinitis
Phase of Trial: Phase IV
Latest Information Update: 27 Jun 2017
Price : $35 *
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- 27 Jun 2017 New trial record
- 19 Jun 2017 Results from this trial have been published in the journal Allergy and were presented at the annual European Academy of Allergy and Clinical Immunology (EAACI) Congress.
- 19 Jun 2017 Results published in a Stallergenes Greer media release.